GN

Ganesh Nayak

Executive Director

Zydus Lifesciences

Zydus Lifesciences Pipeline

DrugIndicationPhase
ZyCoV-DCOVID-19Approved
SaroglitazarDiabetic DyslipidemiaApproved
OxemiaHypertensionApproved
LipaglynType 2 DiabetesApproved
Biosimilar PortfolioOncologyVarious
Generic PipelineMultipleVarious